Company: ERAS
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103868
Chunk: 32

Company: Erasca, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 32
---
 and committee Chairs are set forth in the following chart.

| Name of Director             |     | Audit |     | Compensation |     | Nominating and       
 Corporate Governance |
| James A. Bristol, Ph.D.      |     |       |     | C            |     | X                    |
| Alexander W. Casdin          |     | C†    |     |              |     |                      |
| Julie Hambleton, M.D.        |     | X     |     | X            |     |                      |
| Pratik S. Multani, M.D.      |     |       |     |              |     | X                    |
| Valerie Harding-Start, Ph.D. |     |       |     | X            |     | C                    |
| Jean I. Liu, J.D.            |     | X     |     |              |     |                      |

| C | Committee Chair |

| † | Financial Expert |

Audit Committee The Audit Committee’s main function is to oversee our accounting and financial reporting processes and the audits of our consolidated financial statements. This committee’s responsibilities include, among other things:

| • |     | appointing our independent registered public accounting firm; |

| • |     | evaluating the qualifications, independence and performance of our independent registered public accounting firm; |

| • |     | approving the audit andnon-auditservices to be performed by our independent registered public accounting firm; |

| • |     | reviewing the design, implementation, adequacy and effectiveness of our internal accounting controls and our critical accounting policies; |

| • |     | discussing with management and the independent registered public accounting firm the results of our annual audit and the review of our quarterly unaudited consolidated financial statements; |

| • |     | reviewing, overseeing and monitoring the integrity of our consolidated financial statements and our compliance with legal and regulatory requirements as they relate to financial statements or accounting matters; |

| • |     | reviewing on a periodic basis, or as appropriate, any investment policy and recommending to the Board any changes to such investment policy; |

| • |     | reviewing with management and our auditors any earnings announcements and other public announcements regarding our results of operations; |

| • |     | preparing the report that the SEC requires in our annual proxy statement; |

| • |     | discussing the Company’s policies with respect to risk assessment and risk management, including with respect to cybersecurity; |

| • |     | reviewing and approving any related party transactions and reviewing and monitoring compliance with our